TSE:CRH

CRH Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
C$4.82
C$5.04
52-Week Range N/A
Volume36,923 shs
Average Volume190,654 shs
Market CapitalizationC$357.38 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive CRH News and Ratings via Email

Sign-up to receive the latest news and ratings for CRH Medical and its competitors with MarketBeat's FREE daily newsletter.


CRH Medical logo

About CRH Medical

CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. It also offers a hemorrhoid banding ancillary program, cybersecurity, and a consumer-centric digital application. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada. As of April 22, 2021, CRH Medical Corporation operates as a subsidiary of WELL Health Technologies Corp.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.08 out of 5 stars

Analyst Opinion: 3.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











CRH Medical (TSE:CRH) Frequently Asked Questions

Is CRH Medical a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CRH Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRH, but not buy additional shares or sell existing shares.
View analyst ratings for CRH Medical
or view top-rated stocks.

What stocks does MarketBeat like better than CRH Medical?

Wall Street analysts have given CRH Medical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CRH Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Is CRH Medical a good dividend stock?

CRH Medical pays an annual dividend of C$1.20 per share and currently has a dividend yield of 0.00%.
View CRH Medical's dividend history.

What price target have analysts set for CRH?

2 Wall Street analysts have issued twelve-month price targets for CRH Medical's stock. Their forecasts range from C$5.00 to C$5.10. On average, they anticipate CRH Medical's share price to reach C$5.05 in the next twelve months.
View analysts' price targets for CRH Medical
or view top-rated stocks among Wall Street analysts.

Who are CRH Medical's key executives?

CRH Medical's management team includes the following people:
  • Dr. Tushar M. Ramani, Chairman & CEO (Age 56, Pay $780k)
  • Mr. Richard K. Bear, CFO & Corp. Sec. (Age 58, Pay $560k)
  • Mr. James T. Kreger, Pres of CRH Anesthesia Management (Age 52, Pay $416.65k)
  • Mr. Tom Sanders, VP of Commercial Devel.

Who are some of CRH Medical's key competitors?

What other stocks do shareholders of CRH Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include CRH Medical (CRHM), Aurora Cannabis (ACB), Dollarama (DOL), Trican Well Service (TCW), Alimentation Couche-Tard (ATD.B), Journey Energy (JOY), The Bank of Nova Scotia (BNS), DHX Media (DHX.B), Enbridge (ENB) and ProMetic Life Sciences (PLI).

What is CRH Medical's stock symbol?

CRH Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRH."

How do I buy shares of CRH Medical?

Shares of CRH and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How much money does CRH Medical make?

CRH Medical has a market capitalization of C$0.00 and generates C$106.17 million in revenue each year.

How many employees does CRH Medical have?

CRH Medical employs 133 workers across the globe.

What is CRH Medical's official website?

The official website for CRH Medical is investors.crhsystem.com.

Where are CRH Medical's headquarters?

CRH Medical is headquartered at 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.


This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.